Technology

After years of committing to sustainable practices in his personal life from recycling to using cloth-based diapers, Asim Hussain, currently the director of green software and ecosystems at Intel, began to ask questions about the practices in his work: software development. Developers often asked if their software was secure enough, fast enough, or cost-effective enough…

This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology. The hunter-gatherer groups at the heart of a microbiome gold rush Over the last couple of decades, scientists have come to realize just how important the microbes that crawl all over us are…

This article is from The Technocrat, MIT Technology Review’s weekly tech policy newsletter about power, politics, and Silicon Valley. To receive it in your inbox every Friday, sign up here. We’re already at that time of year when we start looking ahead to what’s coming in 2024. For Technocrat readers (and the rest of the…

Sometimes it’s important to state the obvious. That democracies are fragile but that technology can help. And also that crowdfunding isn’t always the best way to launch an innovative product.

© 2023 TechCrunch. All rights reserved. For personal use only.

To hear the hype from vendors, you would think that the enterprise buyers are all in when it comes to generative AI, but like any newer technology, large companies tend to move cautiously. Throughout this year, as vendors feverishly announced new generative-AI fueled products, CIOs took note. Some companies have actually been looking to cut […]

© 2023 TechCrunch. All rights reserved. For personal use only.

The coming year will be one of seismic political shifts. Over 4 billion people will head to the polls in countries including the United States, Taiwan, India, and Indonesia, making 2024 the biggest election year in history. And election campaigns are using artificial intelligence in novel ways. Earlier this year in the US, the Republican…

This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology. Vertex developed a CRISPR cure. It’s already on the hunt for something better. The company that just got approval to sell the first gene-editing treatment in history, for sickle-cell disease, is already looking…

The company that just got approval to sell the first gene-editing treatment in history, for sickle-cell disease, is already looking for an ordinary drug that could take its place. Vertex Pharmaceuticals has a 50-person team working “to make a pill that doesn’t do gene editing at all,” says David Altshuler, head of research at the…

This article first appeared in The Checkup, MIT Technology Review’s weekly biotech newsletter. To receive it in your inbox every Thursday, and read articles like this first, sign up here. Covid shots do an admirable job of boosting our immune response enough to protect against serious illness, but they don’t boost immunity in the one spot…